CORVUS PHARMACEUTICALS INC. - COMMON STOCK

Corvus Pharmaceuticals Announces New Data Demonstrating CPI-818’s (ITK Inhibitor) Potential to Block HIV Latency Reversal

21 фев 2023 06:00:01 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals Presents Updated Data from CPI-818 (ITK Inhibitor) Phase 1/1b Clinical Trial at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition

12 дек 2022 09:00:00 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Host Investor Conference Call and Webcast on December 12, 2022

05 дек 2022 07:30:00 Источник Nasdaq GlobeNewswire

James Rosenbaum Presented the Distinguished Service Award by the American College of Rheumatology

14 ноя 2022 07:30:00 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results

03 ноя 2022 15:05:02 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Present Updated CPI-818 (ITK Inhibitor) Data at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition

03 ноя 2022 08:52:48 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Provide Business Update and Report Third Quarter 2022 Financial Results on November 3, 2022

27 окт 2022 15:05:01 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant as Potential First Line Treatment for Patients with Renal Cell Cancer

25 окт 2022 15:05:00 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China

26 сен 2022 15:05:00 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference

06 сен 2022 15:05:00 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results

08 авг 2022 15:05:01 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2022 Financial Results on August 8, 2022

28 июл 2022 15:05:01 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals Appoints Dr. James Rosenbaum Senior Vice President of Research

21 июл 2022 15:05:01 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Program Updates at R&D Symposium

10 май 2022 06:30:02 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results

05 май 2022 15:05:03 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Host R&D Symposium on May 10, 2022 in New York

26 апр 2022 06:30:00 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

10 мар 2022 15:05:01 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022

03 мар 2022 15:30:00 Источник Nasdaq GlobeNewswire

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in China

13 янв 2022 17:30:00 Источник Nasdaq GlobeNewswire

New Preclinical Data Highlights Potential for CPI-818 (ITK Inhibitor) as a Therapy for Acute Graft Versus Host Disease in Patients Receiving Bone Marrow Transplantation

13 дек 2021 08:00:00 Источник Nasdaq GlobeNewswire